Screener
Recursion Pharmaceuticals, Inc. RXRX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $556.82M+4.3% | $665.18M+30.6% | $753.92M+25.0% | $667.15M+53.1% | $533.85M+10.6% | ||
| $603.46M+2.8% | $709.56M+21.5% | $812.85M+13.8% | $714.11M+50.6% | $587.16M+12.4% | ||
| $89.62M-25.3% | $95.81M-24.5% | $103.93M-26.3% | $111.71M+32.3% | $120.04M+43.5% | ||
| $160.35M-2.4% | $160.17M+1.3% | $162.16M+8.9% | $162.04M+211% | $164.27M+216% | ||
| $282.89M-17.1% | $294.07M-12.4% | $309.9M-7.7% | $322.34M+845% | $341.32M+793% | ||
| $1.21B-6.9% | $1.34B+2.6% | $1.47B+1.8% | $1.4B+92.6% | $1.3B+67.9% | ||
| $12.67M-34.4% | $20.35M-18.9% | $18.12M-16.2% | $13.94M+517% | $19.31M+413% | ||
| $27.59M-30.5% | $32.79M-17.3% | $37.61M-39.1% | $47.36M-4.5% | $39.69M+23.2% | ||
| $9.44M+7.9% | $9.27M+7.9% | $9.09M+7.9% | $8.92M+8.5% | $8.75M+7.9% | ||
| $119.89M-26.9% | $129.7M-8.7% | $147.71M-21.2% | $155.1M+42.4% | $164.03M+90.5% | ||
| $4.75M-66.5% | $7.18M-56.3% | $9.56M-49.7% | $11.9M-42.0% | $14.2M-38.1% | ||
| $297.67M-22.3% | $314.75M-15.2% | $343.27M-17.0% | $352.58M+74.6% | $383.21M+100% | ||
| 2B0.0% | 2B0.0% | 2B+49,999,900% | 2B0.0% | 2B0.0% | ||
| -$2.32B-28.7% | -$2.19B-34.3% | -$2.08B-45.0% | -$1.97B-57.1% | -$1.81B-56.1% | ||
| $915M-0.5% | $1.02B+9.7% | $1.13B+9.3% | $1.05B+99.6% | $919.15M+57.3% | ||
| $1.21B-6.9% | $1.34B+2.6% | $1.47B+1.8% | $1.4B+92.6% | $1.3B+67.9% |
FAQ
- What are Recursion Pharmaceuticals, Inc.'s total assets?
- Recursion Pharmaceuticals, Inc. (RXRX) holds $1.2B in total assets, down 6.9% year over year.
- How much debt does Recursion Pharmaceuticals, Inc. have?
- Recursion Pharmaceuticals, Inc. carries $80.5M in total debt against $915.0M of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does Recursion Pharmaceuticals, Inc. have?
- Recursion Pharmaceuticals, Inc. holds $556.8M in cash and equivalents.
- Can Recursion Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 5.03 — current assets exceed current liabilities.
- Where does Recursion Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Recursion Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
